CAS: 110452-75-0 - (3R,4aS,5R,6R,6aR,10R,10aS,10bR)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-5-yl 4-(4-methylpiperazin-1-yl)butanoate
Fórmula:C29H48N2O7
InChI:InChI=1/C29H48N2O7/c1-8-26(4)18-20(33)29(36)27(5)19(32)11-12-25(2,3)23(27)22(35)24(28(29,6)38-26)37-21(34)10-9-13-31-16-14-30(7)15-17-31/h8,19,22-24,32,35-36H,1,9-18H2,2-7H3/t19-,22-,23-,24-,26+,27-,28+,29-/m1/s1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | L 858051 REF: 3D-FL157044CAS: 110452-75-0 | Min. 95% | A consultar | Mié 11 Dic 24 |
 | L 858051 REF: TM-T24365CAS: 110452-75-0 | - - - | 1.437,00 €~2.364,00 € | Mar 21 Ene 25 |
Ref: 3D-FL157044
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 11 de Diciembre de 2024
L 858051
CAS:110452-75-0
L 858051 activates adenylate cyclase. It also inhibits glucose transport in rat adipocytes.
Fórmula:
C29H48N2O7
Forma y color:
Solid
Peso molecular:
536.7
Ref: TM-T24365
| 25mg | 1.437,00 € | ||
| 50mg | 1.872,00 € | ||
| 100mg | 2.364,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
